Showing 2121-2130 of 2526 results for "".
- Contact Lens Institute Announces The EASY Way Program to Simplify Contact Lens Wear & Carehttps://modernod.com/news/contact-lens-institute-announces-the-easy-way-program-to-simplify-contact-lens-wear-care/2478377/To generate greater consumer familiarity with contact lens health and safety year-round in the United States and Canada, the Contact Lens Institute (CLI) has launched “The EASY Way” (Eyes, Awareness, Safety and You). The program includes simplified
- UH Professor Developing New Technology to Detect Lens Elasticity Associated With Presbyopiahttps://modernod.com/news/uh-professor-developing-new-technology-to-detect-lens-elasticity-associated-with-presbyopia/2478372/A University of Houston biomedical researcher is developing new technology that will measure the stiffness of the lens in the eye, which is likely associated with presbyopia. Presbyopia is linked to a stiffening of the crystalline lens. There are currently several invest
- In Memoriam: Alan S. Crandall, MDhttps://modernod.com/news/renowned-ophthalmologist-and-humanitarian-alan-s-crandall-md-dies-at-age-73/2478360/Alan S. Crandall, MD, arguably known most for his humanitarian efforts spanning a career of nearly 40 years, died October 2 following a sudden illness. Dr. Crandall practiced at the John A. Moran Eye Center at University of Utah Health for 39 years. Most recently, he served as presidential profes
- EMA Starts Rolling Review of AstraZeneca’s COVID-19 Vaccine Candidate AZD1222https://modernod.com/news/ema-starts-rolling-review-of-astrazenecas-covid-19-vaccine-candidate-azd1222/2478359/The European Medicines Agency said Thursday that its Committee for Medicinal Products for Human Use (CHMP) has initiated a rolling review of AstraZeneca and the University of Oxford’s COVID-19 vaccine candidate AZD1222. The agency explained that the start of the rolling review, the first fo
- Biotech Healthcare Launches Optiflex TRIO Trifocal IOL in Europehttps://modernod.com/news/biotech-healthcare-launches-optiflex-trio-trifocal-iol/2478350/Switzerland-based Biotech Healthcare has announced the European launch of the Optiflex Trio, a diffractive-refractive trifocal toric IOL designed to treat presbyopia and with astigmatism. Its unique diffraction pattern gives a balanced light distribution at all three distances: near, intermediate
- Study: Essilor’s Stellest Lens Slows Down Myopia Progression in Children by More Than 60% After One Yearhttps://modernod.com/news/study-essilors-stellest-lens-slows-down-myopia-progression-in-children-by-more-than-60-after-one-year/2478339/Essilor reported that after 1 year of an ongoing clinical trial, there was a more than 60% slowdown in myopia progression in children on average with the recently launched Stellest lens, compared to a single vision lenses. Essilor launched the Stellest lens in the Wenzhou Medical Universit
- Moran Eye Center Lab Produces World’s First ‘Pathoconnectome’https://modernod.com/news/moran-eye-center-lab-produces-worlds-first-pathoconnectome/2478338/Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons. Moran’s Marclab for Connectomics was the first to complete a map of the circuitry of the retina, or conne
- Micro Labs USA Launches Two New Glaucoma Drugshttps://modernod.com/news/new-products-launched-by-micro-labs-usa-inc/2478327/Micro Labs USA is launching two products for the treatment of glaucoma in the United States: Dorzolamide 2% and Dorzolamide-Timolol 22.3-6.8 mg/mL. Micro Labs USA said there are additional ophthalmic products under developm
- Trump Signs Executive Orders on Preexisting Condition Protections, Surprise Billinghttps://modernod.com/news/trump-signs-executive-orders-on-preexisting-condition-protections-surprise-billing/2478328/President Donald Trump signed an executive order that declares it a national policy to protect patients with preexisting conditions regardless of the fate of the Affordable Care Act (ACA)—but just how they’ll force insurers to comply remains unclear, according to a FierceHealthcare
- How is Night Vision Maintained During Retinal Disease? Research Provides New Insighthttps://modernod.com/news/how-is-night-vision-maintained-during-retinal-disease-research-provides-new-insight/2478325/New research from a team including scientists from the John A. Moran Eye Center at the University of Utah provides insight on how people with retinal degenerative disease can maintain their night vision for a relatively long period of time. A